[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Vascular Stent-Asia Pacific Market Status and Trend Report 2013-2023

December 2017 | 155 pages | ID: V764B3255E9EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Vascular Stent-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole Asia Pacific and Regional Market Size of Vascular Stent 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stent in Asia Pacific, with company and product introduction, position in the Vascular Stent market
Market status and development trend of Vascular Stent by types and applications
Cost and profit status of Vascular Stent, and marketing status
Market growth drivers and challenges

The report segments the Asia Pacific Vascular Stent market as:

Asia Pacific Vascular Stent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

China
Japan
Korea
India
Southeast Asia
Australia

Asia Pacific Vascular Stent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

BMS
BVS
Drug Eluting

Asia Pacific Vascular Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Hospital
Cardiology Center
ASC

Asia Pacific Vascular Stent Market: Players Segment Analysis (Company and Product introduction, Vascular Stent Sales Volume, Revenue, Price and Gross Margin):

Medtronic
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK
B. Braun Melsungen
Terumo Corporation
STENTYS
MicroPort Scientific Corporation
Meril Life Sciences
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix
Lombard Medical Technologies
Translumina
JOTEC

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF VASCULAR STENT

1.1 Definition of Vascular Stent in This Report
1.2 Commercial Types of Vascular Stent
  1.2.1 BMS
  1.2.2 BVS
  1.2.3 Drug Eluting
1.3 Downstream Application of Vascular Stent
  1.3.1 Hospital
  1.3.2 Cardiology Center
  1.3.3 ASC
1.4 Development History of Vascular Stent
1.5 Market Status and Trend of Vascular Stent 2013-2023
  1.5.1 Asia Pacific Vascular Stent Market Status and Trend 2013-2023
  1.5.2 Regional Vascular Stent Market Status and Trend 2013-2023

CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Vascular Stent in Asia Pacific 2013-2017
2.2 Consumption Market of Vascular Stent in Asia Pacific by Regions
  2.2.1 Consumption Volume of Vascular Stent in Asia Pacific by Regions
  2.2.2 Revenue of Vascular Stent in Asia Pacific by Regions
2.3 Market Analysis of Vascular Stent in Asia Pacific by Regions
  2.3.1 Market Analysis of Vascular Stent in China 2013-2017
  2.3.2 Market Analysis of Vascular Stent in Japan 2013-2017
  2.3.3 Market Analysis of Vascular Stent in Korea 2013-2017
  2.3.4 Market Analysis of Vascular Stent in India 2013-2017
  2.3.5 Market Analysis of Vascular Stent in Southeast Asia 2013-2017
  2.3.6 Market Analysis of Vascular Stent in Australia 2013-2017
2.4 Market Development Forecast of Vascular Stent in Asia Pacific 2018-2023
  2.4.1 Market Development Forecast of Vascular Stent in Asia Pacific 2018-2023
  2.4.2 Market Development Forecast of Vascular Stent by Regions 2018-2023

CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES

3.1 Whole Asia Pacific Market Status by Types
  3.1.1 Consumption Volume of Vascular Stent in Asia Pacific by Types
  3.1.2 Revenue of Vascular Stent in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
  3.2.1 Market Status by Types in China
  3.2.2 Market Status by Types in Japan
  3.2.3 Market Status by Types in Korea
  3.2.4 Market Status by Types in India
  3.2.5 Market Status by Types in Southeast Asia
  3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Vascular Stent in Asia Pacific by Types

CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Vascular Stent in Asia Pacific by Downstream Industry
4.2 Demand Volume of Vascular Stent by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Vascular Stent by Downstream Industry in China
  4.2.2 Demand Volume of Vascular Stent by Downstream Industry in Japan
  4.2.3 Demand Volume of Vascular Stent by Downstream Industry in Korea
  4.2.4 Demand Volume of Vascular Stent by Downstream Industry in India
  4.2.5 Demand Volume of Vascular Stent by Downstream Industry in Southeast Asia
  4.2.6 Demand Volume of Vascular Stent by Downstream Industry in Australia
4.3 Market Forecast of Vascular Stent in Asia Pacific by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENT

5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Vascular Stent Downstream Industry Situation and Trend Overview

CHAPTER 6 VASCULAR STENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC

6.1 Sales Volume of Vascular Stent in Asia Pacific by Major Players
6.2 Revenue of Vascular Stent in Asia Pacific by Major Players
6.3 Basic Information of Vascular Stent by Major Players
  6.3.1 Headquarters Location and Established Time of Vascular Stent Major Players
  6.3.2 Employees and Revenue Level of Vascular Stent Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 VASCULAR STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Medtronic
  7.1.1 Company profile
  7.1.2 Representative Vascular Stent Product
  7.1.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Medtronic
7.2 Abbott Laboratories
  7.2.1 Company profile
  7.2.2 Representative Vascular Stent Product
  7.2.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
  7.3.1 Company profile
  7.3.2 Representative Vascular Stent Product
  7.3.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 BIOTRONIK
  7.4.1 Company profile
  7.4.2 Representative Vascular Stent Product
  7.4.3 Vascular Stent Sales, Revenue, Price and Gross Margin of BIOTRONIK
7.5 B. Braun Melsungen
  7.5.1 Company profile
  7.5.2 Representative Vascular Stent Product
  7.5.3 Vascular Stent Sales, Revenue, Price and Gross Margin of B. Braun Melsungen
7.6 Terumo Corporation
  7.6.1 Company profile
  7.6.2 Representative Vascular Stent Product
  7.6.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 STENTYS
  7.7.1 Company profile
  7.7.2 Representative Vascular Stent Product
  7.7.3 Vascular Stent Sales, Revenue, Price and Gross Margin of STENTYS
7.8 MicroPort Scientific Corporation
  7.8.1 Company profile
  7.8.2 Representative Vascular Stent Product
  7.8.3 Vascular Stent Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.9 Meril Life Sciences
  7.9.1 Company profile
  7.9.2 Representative Vascular Stent Product
  7.9.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Meril Life Sciences
7.10 Vascular Concepts
  7.10.1 Company profile
  7.10.2 Representative Vascular Stent Product
  7.10.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Vascular Concepts
7.11 W. L. Gore and Associates
  7.11.1 Company profile
  7.11.2 Representative Vascular Stent Product
  7.11.3 Vascular Stent Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
7.12 C. R. Bard
  7.12.1 Company profile
  7.12.2 Representative Vascular Stent Product
  7.12.3 Vascular Stent Sales, Revenue, Price and Gross Margin of C. R. Bard
7.13 Endologix
  7.13.1 Company profile
  7.13.2 Representative Vascular Stent Product
  7.13.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Endologix
7.14 Lombard Medical Technologies
  7.14.1 Company profile
  7.14.2 Representative Vascular Stent Product
  7.14.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Lombard Medical Technologies
7.15 Translumina
  7.15.1 Company profile
  7.15.2 Representative Vascular Stent Product
  7.15.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Translumina
7.16 JOTEC

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENT

8.1 Industry Chain of Vascular Stent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENT

9.1 Cost Structure Analysis of Vascular Stent
9.2 Raw Materials Cost Analysis of Vascular Stent
9.3 Labor Cost Analysis of Vascular Stent
9.4 Manufacturing Expenses Analysis of Vascular Stent

CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENT

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications